270 likes | 413 Views
Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk A Systematic Review and Meta-analysis. Chowdhury et al, 2014, Ann Int Med. (Quick) paper summary. Aim: Associations between fatty acids and coronary disease Method: Meta-analysis of prospective trials
E N D
Association of Dietary, Circulating, and Supplement Fatty Acids WithCoronary RiskA Systematic Review and Meta-analysis Chowdhury et al, 2014, Ann Int Med
(Quick) paper summary • Aim: Associations between fatty acids and coronary disease • Method: Meta-analysis of prospective trials • Dietary FA intake • Biomarkers of plasma FAs • Intervention (supplementation) trials • Results (later) • Conclusions: ”Evidence does not clearly support CV guidelines that encourage high consumption of polyunsaturated FAs, and low consumption of total SFAs”
Scientist backlash? • Complaints • Controversy • Calls (for retraction): Not universal…..
Proposed resolution • Consider the history of the paper • Read the results • Consider the methodology • What was done • What was not done • Consider the original studies • Consider other research
2. Read the results • (now there is a novelty).
2. Read the results • Plasma SFAs
2. Read the results • Plasma MUFAs
2. Read the results • Plasma PUFAs (ω-3) (remember – EVERYTHING we knew about diet was wrong).
2. Read the results • Plasma PUFAs (ω-6)
2. Read the results • Intervention (supplementation) trials
2. Read the results • Self-reported habitual intake of total SFA not associated with cardiac events • Self-reported habitual intake of total MUFA not associated with cardiac events • Self-reported habitual intake of α-linolenic not associated with cardiac events • Self-reported habitual intake of LC ω-3 protective • Self-reported habitual intake of Total ω -6 not associated with cardiac events • Total trans fat associated
2. Read the results • Plasma SFAs: only 17:0 protective. 14:0; 15:0, 16:0, 15:0, 18:0 not associated • Total MUFA not associated • All LC ω-3 strongly protective individually • No evidence that total LC ω -3 associated • Protective effect of ARA, no association with other ω-6
2. Read the results • Intervention trials showed no effect of supplementation for α-linolenic, total LC ω-6, or ω-6
My first conclusions • Different FAs have different associations with outcomes • Those most associated with a protective effect have not been measured in the diet, nor studied in interventions • But, no evidence that total saturated fat (intake / plasma) associated with events • Convincing evidence that some ω-3 protective, although this has not been studied in an intervention trial.
In defense of the authors: • … do not clearly support .. guidelines that promote high consumption of ω-6 PUFA and … reduced consumption of SFA • LC ω -3 PUFAs in primary prevention • odd-chain SFAs (…milk or dairy consumption) may have less deleterious effects
3. Consider the methodology • Nutrient density substitution models convey information on dietary substitution; associations do not.
4. Consider the original samples • Timeframe • Participants & baseline characteristics • Event rate was up to 42%
Acknowledgements • DariushMozaffarian* • Brian Steffen* • American Heart Association* *The views expressed in this presentation are not necessarily the views of the organizations / individuals
Further discussion • Is this an irresponsible paper? • If so – who was irresponsible? • Should we reconsider guidelines on saturated fat? • Do YOU know what the guidelines are? • What about other outcomes? • The role of carbohydrates